Article

Cole National accepts Luxottica's final offer

Cleveland-Shareholders of Cole National Corp., the parent company of Pearl Vision, Sears Optical eyewear shops, and Things Remembered gift stores, have approved an amended deal to merge with Italian eyewear manufacturer Luxottica Group SpA.

Cleveland-Shareholders of Cole National Corp., the parent company of Pearl Vision, Sears Optical eyewear shops, and Things Remembered gift stores, have approved an amended deal to merge with Italian eyewear manufacturer Luxottica Group SpA.

The new $495 million deal increases Cole National's per-share price from $22.50 to $27.50 following a tumultuous process that saw several simultaneous bidders driving the price up from the original $19.65 price Luxottica offered in July 2003. Moulin International Holdings Ltd. of Hong Kong, the largest eyewear manufacturer in Asia, had jumped into the game in April 2004, just days before a stockholder meeting to consider the Luxottica offer. However, Moulin ran into trouble securing financing, giving Luxottica time to increase its offer.

The deal gives Luxottica some 2,200 additional outlets around the country. Cole Vision last posted a profit in fiscal 2000, and last year reported a $10.7 million loss.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.